Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Steglatro

    - PMLiVE

    ViiV Healthcare receives NICE recommendation for HIV prevention therapy

    The treatment is the first and only long-acting HIV prevention option available on the NHS in England and Wales

    - PMLiVE

    Pfizer’s Lorviqua recommended by NICE for lung cancer

    Lung cancer is the leading cause of cancer-related deaths worldwide

    - PMLiVE

    MSD receives NICE recommendation for Keytruda in advanced endometrial cancer

    More than 9,700 new cases of endometrial cancer are diagnosed every year in the UK

    - PMLiVE

    Merck unveils $3bn cost-cutting plan to support pipeline and new product launches

    A new restructuring programme has been approved to support the initiative

    - PMLiVE

    NICE recommends ALK’s immunotherapy to target underlying cause of hay fever

    An estimated 26,800 people in England with moderate-to-severe cases could benefit from Itulazax

    - PMLiVE

    NICE recommends BeOne’s Brukinsa to treat mantle cell lymphoma on NHS

    Approximately 600 people are affected by the form of non-Hodgkin lymphoma every year in the UK

    - PMLiVE

    Novartis’ Kisqali recommended by NICE to treat broad early breast cancer population

    The drug was previously available only for patients whose cancer had spread to nearby lymph nodes

    - PMLiVE

    Vertex’s triple combination cystic fibrosis therapy Alyftrek recommended by NICE

    The rare inherited disease affects approximately 11,000 people in the UK

    - PMLiVE

    Boehringer’s Spevigo recommended by NICE for generalised pustular psoriasis

    The rare form of psoriasis can lead to serious complications such as sepsis and heart failure

    - PMLiVE

    AstraZeneca’s Forxiga recommended by NICE for wider chronic kidney disease use

    An estimated 7.2 million people in the UK are living with the progressive condition

    - PMLiVE

    MSD receives MHRA approval for adult-specific pneumococcal vaccine Capvaxive

    Illnesses caused by Streptococcus pneumoniae are currently considered a major public health problem by WHO

    - PMLiVE

    NHS patients to access Theramex’s endometriosis pill following NICE recommendation

    The once-a-day drug has been recommended for patients with a history of previous medical or surgical treatment

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links